1492 Capital Management LLC Has $3.77 Million Stock Position in Astrana Health, Inc. $ASTH

1492 Capital Management LLC lessened its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 8.4% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 153,700 shares of the company’s stock after selling 14,058 shares during the period. Astrana Health makes up approximately 1.4% of 1492 Capital Management LLC’s portfolio, making the stock its 26th biggest position. 1492 Capital Management LLC’s holdings in Astrana Health were worth $3,769,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of ASTH. Louisiana State Employees Retirement System acquired a new stake in shares of Astrana Health during the 1st quarter valued at $468,000. Invesco Ltd. grew its holdings in shares of Astrana Health by 46.0% during the fourth quarter. Invesco Ltd. now owns 355,216 shares of the company’s stock worth $8,813,000 after purchasing an additional 111,980 shares during the last quarter. VARCOV Co. acquired a new position in shares of Astrana Health in the fourth quarter valued at approximately $744,000. Wellington Management Group LLP increased its stake in shares of Astrana Health by 418.3% in the fourth quarter. Wellington Management Group LLP now owns 738,853 shares of the company’s stock valued at $18,331,000 after buying an additional 596,293 shares during the period. Finally, Millennium Management LLC bought a new position in Astrana Health in the 4th quarter valued at approximately $334,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Price Performance

Astrana Health stock opened at $44.51 on Friday. The stock’s 50 day moving average is $37.46 and its 200 day moving average is $28.74. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.35 and a quick ratio of 1.35. The firm has a market cap of $2.48 billion, a P/E ratio of 72.97 and a beta of 1.00. Astrana Health, Inc. has a one year low of $18.08 and a one year high of $44.59.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Thursday, May 7th. The company reported $0.74 EPS for the quarter, beating the consensus estimate of $0.29 by $0.45. The business had revenue of $965.10 million for the quarter, compared to analysts’ expectations of $949.21 million. Astrana Health had a return on equity of 9.22% and a net margin of 0.86%.The firm’s revenue was up 55.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.42 earnings per share. As a group, research analysts expect that Astrana Health, Inc. will post 1.25 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Barclays upgraded shares of Astrana Health from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $37.00 to $50.00 in a research report on Tuesday, May 26th. Needham & Company LLC upped their price target on shares of Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a research report on Friday, May 8th. Zacks Research raised shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 11th. Robert W. Baird set a $45.00 price target on shares of Astrana Health in a report on Friday, May 8th. Finally, Truist Financial boosted their price objective on shares of Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a research note on Thursday, May 14th. Seven equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $45.00.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.